Privia Health Announces Secondary Offering

0
237


ARLINGTON, Va., Nov. 15, 2022 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA, or “Privia Health” or the “Company”) right now introduced the graduation of an underwritten public providing of 5,000,000 shares of frequent inventory by sure promoting stockholders. Such promoting stockholders additionally intend to grant the underwriters a 30-day choice to buy as much as a further 750,000 shares of the Company’s frequent inventory.

The Company won’t obtain any of the proceeds from the sale of the shares of its frequent inventory being supplied by the promoting stockholders, and the promoting stockholders will bear the prices related to the sale of such shares, together with underwriting reductions and commissions.

Goldman Sachs & Co. LLC is performing as lead book-running supervisor for the proposed providing of frequent inventory and as consultant of the underwriters for the proposed providing. Credit Suisse, Jefferies and William Blair are performing as lively book-running managers. Canaccord Genuity and SVB Securities are performing as book-running managers. NCMG is performing as co-manager.

A shelf registration assertion on Form S-3 (together with a prospectus) regarding the securities being offered within the providing was deemed robotically efficient upon submitting with the Securities and Exchange Commission (the “SEC”) on November 15, 2022. The providing shall be made solely by the use of a prospectus complement and an accompanying prospectus. You could receive these paperwork, together with the preliminary prospectus complement, without cost by visiting EDGAR on the SEC web site at www.sec.gov, or by contacting: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by way of phone: 1-866-471-2526, or by way of electronic mail: [email protected] mail.gs.com.

This press launch is neither a proposal to promote nor a solicitation of a proposal to purchase any securities, nor shall it represent a proposal, solicitation or sale of any securities in any state or jurisdiction through which such supply, solicitation or sale can be illegal previous to the registration or qualification below the securities legal guidelines of any such state or jurisdiction.

About Privia Health

Privia Health™ is a technology-driven, nationwide doctor enablement firm that collaborates with medical teams, well being plans, and well being techniques to optimize doctor practices, enhance affected person experiences, and reward medical doctors for delivering high-value care in each in-person and digital settings. Privia Health’s platform is led by prime business expertise and distinctive doctor management, and consists of scalable operations and end-to-end, cloud-based expertise that reduces pointless healthcare prices, achieves higher outcomes, and improves the well being of sufferers and the well-being of suppliers.

Cautionary Note Regarding Forward-Looking Statements

This press launch incorporates statements that represent “forward-looking statements,” together with with respect to the proposed public providing. No assurance will be provided that the providing mentioned above shall be accomplished on the phrases described, or in any respect. These forward-looking statements are topic to plenty of dangers and uncertainties, lots of that are tough to foretell and past Privia Health’s management, which might trigger precise outcomes to vary materially from these indicated within the forward-looking statements. Those elements embrace, however should not restricted to, the danger elements set forth in Privia Health’s filings with the SEC, together with Privia Health’s most just lately filed Annual Report on Form 10-Okay and subsequent reviews on Form 10-Q and Form 8-Okay, because the case could also be. Copies can be found on the SEC’s web site at www.sec.gov. Privia Health undertakes no obligation to replace these statements for revisions or adjustments after the date of this press launch, besides as required by legislation.

Contact:
Robert P. Borchert
SVP, Investor & Corporate Communications
[email protected]
[email protected]
817.783.4841



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here